Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
61 Leser
Artikel bewerten:
(0)

Research and Markets - Global Microarray Market 2016-2020: Increase in Focus on Drug Discovery and Development with Agilent Technologies, Illumina, Thermo Fisher Scientific & Merck Dominating

DUBLIN, Dec 6, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Microarray Market 2016-2020" report to their offering.

The global microarray market to grow at a CAGR of 14.34% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global microarray market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of microarray solutions such as instruments and consumables. The report also includes a discussion of the key vendors operating in this market.

There is an increase in focus on drug discovery and development by pharmaceutical and biotechnology companies, as well as by research institutes for several diseases. Microarrays technologies are widely used in target classification, target authentication, pathway analysis, compound profiling, and toxicology studies, which are critical factors in drug discovery and development.

According to the report, Microarray technologies, which involve miniaturization, are emerging in the fields of genomics and proteomics, thereby enabling high-throughput processing. These technologies are adopted in genotyping, mutation screening, protein interaction studies, and gene expression analysis. The technology also helps in a better understanding of the inter-relation among genes, hence driving the global microarray market.

Further, the report states that advanced microarray instruments with specific and advanced features are expensive to procure and maintain, which can hinder their adoption in the market. The monitors and other portable immunodiagnostics such as POC testing products for gene testing must comply with the changing and periodic reviews of strict standards and regulations, which also increases their maintenance cost.

Key vendors

  • Agilent Technologies
  • Illumina
  • Thermo Fisher Scientific
  • Merck

Other prominent vendors

  • Applied Microarrays
  • Arrayit
  • AXO Science
  • BioCat
  • BioGenex
  • Biometrix Technology
  • Cepheid
  • GE Healthcare
  • InDevR
  • LC Sciences
  • Perkin Elmer
  • Phalanx Biotech
  • Qiagen
  • Takara Bio
  • US Biomax.

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Geographical segmentation

Part 07: Market segmentation by application

Part 08: Market segmentation by product type

Part 09: Market segmentation by technology

Part 10: Market drivers

Part 11: Impact of drivers

Part 12: Market challenges

Part 13: Impact of drivers and challenges

Part 14: Market trends

Part 15: Vendor landscape

Part 16: Key vendor analysis

Part 17: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/64wltv/global_microarray

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.